Manfredi, Paolo L.
Relmada Therapeutics, Inc. (United States)
6 papers on CoChatORCID 0000-0002-7242-9450
Most cited papers
- Verified
REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial
Fava, M., Stahl, S., Pani, L., De Martin, S., Pappagallo, M., Guidetti, C., Alimonti, A., Bettini, E., Mangano, R. M., Wessel, T., et al. (2022) · American Journal of Psychiatry
Treatment of Major DepressionNeuroscience and Neuropharmacology Research
Cited by 83
- Verified
Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors
Bettini, E., Stahl, S. M., De Martin, S., Mattarei, A., Sgrignani, J., Carignani, C., Nola, S., Locatelli, P., Pappagallo, M., Inturrisi, C. E., et al. (2022) · Pharmaceuticals
Neuroscience and Neuropharmacology ResearchTreatment of Major Depression
Cited by 31
- Verified
REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical Study
De Martin, S., Gabbia, D., Folli, F., Bifari, F., Fiorina, P., Ferri, N., Stahl, S., Inturrisi, C. E., Pappagallo, M., Traversa, S., et al. (2021) · Frontiers in Pharmacology
Treatment of Major DepressionNerve injury and regeneration
Cited by 28
- Verified
The N-methyl-D-aspartate receptor antagonist d-methadone acutely improves depressive-like behavior in the forced swim test performance of rats.
Hanania, T., Manfredi, P., Inturrisi, C., & Vitolo, O. V. (2020) · Experimental and Clinical Psychopharmacology
Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior
Cited by 27
- Verified
Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive Disorder
Guidetti, C., Serra, G., Pani, L., Pappagallo, M., Maglio, G., Martin, S. D., Mattarei, A., Folli, F., Manfredi, P. L., & Fava, M. (2023) · The Primary Care Companion For CNS Disorders
Treatment of Major DepressionSchizophrenia research and treatment
Cited by 4
- Verified
A Phase 2a Double-Blind Randomized Trial of REL-1017 (Esmethadone) in Patients with MDD: Analysis of Subscales from the Symptoms of Depression Questionnaire
Guidetti, C., Fava, M., Pani, L., Pappagallo, M., Serra, G., DeMartin, S., Mattarei, A., & Manfredi, P. L. (2022) · CNS Spectrums
Treatment of Major DepressionBipolar Disorder and Treatment
Cited by 3
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free